ResultsIQ › Latest results › Punjab Chemicals & Crop Protection Limited

Punjab Chemicals & Crop Protection Limited Q3 FY26 results deck summary

NSE: PUNJABCHEM · BSE: 506618

Results deck of 29 Jan 2026, summarised by AI from the filing.

Revenue ₹246.6 cr, up 15.3% YoY, driven by improvement in domestic and exports sales and increased demand.

Key takeaways

Q3 FY26 revenue Revenue ₹246.6 cr, up 15.3% YoY, driven by improvement in domestic and exports sales and increased demand.
Driver Growth driven by improvement in domestic and exports sales and Q3 FY26 increased demand.
Risk One block shutdown at Derabassi in Q4 to debottleneck capacity may impact production.

Punjab Chemicals & Crop Protection Limited Q1 FY27 results

As filed: Revenue ₹347 cr (+9% year on year), EBITDA ₹40.8 cr (+17% year on year), PAT ₹22.1 cr (+5% year on year), EBITDA margin 11.8% (+82 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

Q4 FY26: Revenue ₹209 cr (+3% year on year), EBITDA ₹27.5 cr (+6% year on year), PAT ₹11.0 cr (+57% year on year), EBITDA margin 13.2% (+32 bps). Score 50 of 100, In line with trend. Revenue, EBITDA and profit growth were in line with the company's own trend. EBITDA margin rose 32 bps year on year. Revenue fell 15% from last quarter. Share price after the results: −12.2% in 28 days (Nifty 500: −0.1%).
Q3 FY26: Revenue ₹247 cr (+15% year on year), EBITDA ₹29.6 cr (+56% year on year), PAT ₹13.8 cr (+159% year on year), EBITDA margin 12.0% (+311 bps). Score 76 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit before exceptional items growth were well above it. EBITDA margin rose 311 bps year on year. Revenue fell 3% from last quarter. Share price after the results: +17.5% in 30 days (Nifty 500: +1.5%).
Q2 FY26: Revenue ₹255 cr (+5% year on year), EBITDA ₹27.0 cr (+4% year on year), PAT ₹19.0 cr (+58% year on year), EBITDA margin 10.6% (−16 bps). Score 49 of 100, In line with trend. Revenue and EBITDA growth were in line with the company's own trend; profit growth was above it. EBITDA margin fell 16 bps year on year. Other income 27% of PBT. Revenue fell 20% from last quarter. Share price after the results: +1.4% in 30 days (Nifty 500: −0.4%).
Q1 FY26: Revenue ₹320 cr (+32% year on year), EBITDA ₹35.0 cr (+30% year on year), PAT ₹21.0 cr (+62% year on year), EBITDA margin 10.9% (−22 bps). Score 84 of 100, Above trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were above it. EBITDA margin fell 22 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −13.7% in 29 days (Nifty 500: −0.3%).
Q4 FY25: Revenue ₹202 cr (+3% year on year), EBITDA ₹26.0 cr (+100% year on year), PAT ₹7.0 cr (+250% year on year), EBITDA margin 12.9% (+627 bps). Score 85 of 100, Above trend. Revenue growth was in line with the company's own trend; EBITDA and profit before exceptional items growth were well above it. EBITDA margin rose 627 bps year on year. Revenue fell 6% from last quarter. Share price after the results: +10.2% in 30 days (Nifty 500: +3.1%).
Q3 FY25: Revenue ₹214 cr (0% year on year), EBITDA ₹19.0 cr (−27% year on year), PAT ₹6.0 cr (−45% year on year), EBITDA margin 8.9% (−327 bps). Score 25 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 327 bps year on year. Revenue fell 12% from last quarter.
Q2 FY25: Revenue ₹242 cr (0% year on year), EBITDA ₹26.0 cr (−28% year on year), PAT ₹12.0 cr (−33% year on year), EBITDA margin 10.7% (−413 bps). Score 14 of 100, Below trend. EBITDA margin fell 413 bps year on year. Not enough history for a trend yet: scored on growth alone. Profit fell 8% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Punjab Chemicals & Crop Protection Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.